FDA Inspection 772469 — Oklahoma Blood Institute East Central
The FDA completed an inspection of Oklahoma Blood Institute East Central on March 7, 2012 in Ada, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 7, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ada, OK (United States)